Ensystex responds to EPA imidacloprid announcement
As PMP reported Jan. 6, the U.S. Environmental Protection Agency has announced a preliminary pollinator risk assessment for the neonicotinoid insecticide imidacloprid. What follows is a Jan. 20 statement from Ensystex, which manufactures imidacloprid for several of its products, on the topic: Ensystex has... Read more»
RISE responds to EPA imidacloprid announcement
As PMP reported Jan. 6, the U.S. Environmental Protection Agency has announced a preliminary pollinator risk assessment for the neonicotinoid insecticide imidacloprid. What follows is a Jan. 13 statement from Karen Reardon, VP of Public Affairs for RISE (Responsible Industry for a Sound... Read more»
Rockwell responds to EPA imidacloprid announcement
As PMP reported Jan. 6, the U.S. Environmental Protection Agency has announced a preliminary pollinator risk assessment for the neonicotinoid insecticide imidacloprid. What follows is a Jan. 13 statement from Dr. Cisse Spragins, president and founder of Rockwell Labs, on the... Read more»
Bayer responds to EPA imidacloprid announcement
As PMP reported Jan. 6, the U.S. Environmental Protection Agency has announced a preliminary pollinator risk assessment for the neonicotinoid insecticide imidacloprid. What follows is a Jan. 12 statement from Bayer CropScience, which is considered to be the primary manufacturer... Read more»
NPMA responds to EPA imidacloprid announcement
As PMP reported Jan. 6, the U.S. Environmental Protection Agency has announced a preliminary pollinator risk assessment for the neonicotinoid insecticide imidacloprid. What follows is a statement from the National Pest Management Association (NPMA) about the possible impact this primarily... Read more»
BREAKING: EPA assesses imidacloprid impact on bees
On Jan. 6, the U.S. Environmental Protection Agency (EPA) announced a preliminary pollinator risk assessment for the neonicotinoid insecticide imidacloprid. EPA’s assessment, prepared in collaboration with California’s Department of Pesticide Regulation, indicates that imidacloprid potentially poses risk to hives when... Read more»